IRBETAN irbesartan 75mg film-coated tablet blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

irbesartan, Quantity: 75 mg

Disponible desde:

Medis Pharma Pty Ltd

Designación común internacional (DCI):

Irbesartan

formulario farmacéutico:

Tablet, film coated

Composición:

Excipient Ingredients: lactose monohydrate; croscarmellose sodium; magnesium stearate; povidone; titanium dioxide; hypromellose; macrogol 4000

Vía de administración:

Oral

Unidades en paquete:

30s

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Irbesartan is indicated for the following: For the treatment of hypertension. For delaying the progression of renal disease in hypertensive type II diabetics with persistent micro-albuminuria (equal to or greater than 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.

Resumen del producto:

Visual Identification: White to off-white, oval shaped, biconvex, film coated tablet, debossed with "L172" on one side and "75" on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estado de Autorización:

Licence status A

Fecha de autorización:

2012-11-13